US 8846056
Anti-RSV immunogens and methods of immunization
granted A61KA61K2039/5252A61K2039/545
Quick answer
US patent 8846056 (Anti-RSV immunogens and methods of immunization) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control
- Grant date
- Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/5252, A61K2039/545, A61K2039/555, A61K2039/55505